Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  2014-10-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1164/rccm.201403-0544OCPMID 25162465PMCID PMC4299578
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Förster resonance energy transfer competitive displacement assay for human soluble epoxide hydrolase.

  2013cited by this paper
• Exhaled breath condensate eicosanoid levels associate with asthma and its severity.

  2013cited by this paper
• Efficacy and safety of 15(R/S)‐methyl‐lipoxin A4 in topical treatment of infantile eczema

  2013cited by this paper
• Resolution of inflammation in asthma.

  2012cited by this paper
• Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes.

  2012cited by this paper
• Homocysteine Upregulates Soluble Epoxide Hydrolase in Vascular Endothelium In Vitro and In Vivo

  2012cited by this paper
• Asthma phenotypes: the evolution from clinical to molecular approaches

  2012cited by this paper
• Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program.

  2012cited by this paper
• Aspirin-Trigge red-Resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury

  2012cited by this paper
• Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program.

  2010cited by this paper
• Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.

  2010cited by this paper
• The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses.

  2010cited by this paper
• Lovastatin Decreases Acute Mucosal Inflammation Via 15-epi-Lipoxin A4

  2010cited by this paper
• 1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain.

  2010cited by this paper
• 17,18-epoxyeicosatetraenoic acid targets PPARγ and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase.

  2010cited by this paper
• Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury.

  2009cited by this paper
• Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma.

  2008cited by this paper
• Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation

  2008cited by this paper
• EET displays anti-inflammatory effects in TNF-alpha stimulated human bronchi: putative role of CPI-17.

  2008cited by this paper
• Epoxyeicosatrienoic acid relaxing effects involve Ca2+-activated K+ channel activation and CPI-17 dephosphorylation in human bronchi.

  2007cited by this paper
• Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.

  2007cited by this paper
• Measurement of Soluble Epoxide Hydrolase (sEH) Activity

  2007cited by this paper
• The role of platelets in the pathophysiology of asthma

  2007cited by this paper
• Platelet activation in allergic asthma patients during allergen challenge with Dermatophagoides pteronyssinus

  2006cited by this paper
• Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation.

  2006cited by this paper
• Diminished lipoxin biosynthesis in severe asthma.

  2005cited by this paper
• Exhaled breath condensate: methodological recommendations and unresolved questions

  2005cited by this paper
• Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor.

  2005cited by this paper
• Induced sputum 8-isoprostane concentrations in inflammatory airway diseases.

  2005cited by this paper
• Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound.

  2005cited by this paper
• Corticosteroid resistance in airway disease.

  2004cited by this paper
• Platelets are essential for leukocyte recruitment in allergic inflammation.

  2003cited by this paper
• Structural refinement of inhibitors of urea-based soluble epoxide hydrolases.

  2002cited by this paper
• Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4

  2002cited by this paper
• Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.

  2001cited by this paper
• Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics. Evidence for oxidant stress.

  1999cited by this paper
• Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma.

  1993cited by this paper
• The effects of lipoxin A4 on airway responses in asthmatic subjects.

  1992cited by this paper
• Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases.

  1990cited by this paper
• Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils

  1990cited by this paper
• Leukotrienes and lipoxins: structures, biosynthesis, and biological effects.

  1987cited by this paper

• Inhibition of Soluble Epoxide Hydrolase Reduces Inflammation and Myocardial Injury in Arrhythmogenic Cardiomyopathy

  2025cites this paper
• Exploring the interplay between oxidative stress and autophagy in asthma: Pathophysiology and therapeutic potential.

  2025cites this paper
• Inhibition of Soluble Epoxide Hydrolase Reduces Inflammation and Myocardial Injury in Arrhythmogenic Cardiomyopathy

  2024cites this paper
• Effects Of Age on Lacrimal Gland Bioactive Lipids.

  2024cites this paper
• Enhancing cancer immunotherapy via inhibition of soluble epoxide hydrolase

  2024cites this paper
• Differential lipid signaling from CD4+ and CD8+ T cells contributes to type 1 diabetes development

  2024cites this paper
• Lower serum 15-HETE level predicts nasal ILC2 accumulation during COX-1 inhibition in AERD

  2023cites this paper
• Bronchial Asthma, Airway Remodeling and Lung Fibrosis as Successive Steps of One Process

  2023cites this paper
• Eicosanoids Signals in SARS-CoV-2 Infection: A Foe or Friend

  2023cites this paper
• Multi-Omics Analysis of Lung Tissue Demonstrates Changes to Lipid Metabolism during Allergic Sensitization in Mice

  2023cites this paper
• Inhibition of soluble epoxide hydrolase relieves adipose inflammation via modulating M1/M2 macrophage polarization to alleviate airway inflammation and hyperresponsiveness in obese asthma.

  2023cites this paper
• Soluble epoxide hydrolase inhibition enhances production of specialized pro‐resolving lipid mediator and promotes macrophage plasticity

  2022cites this paper
• The Role of Defective Epithelial Barriers in Allergic Lung Disease and Asthma Development

  2022cites this paper
• Novel Immunomodulatory Therapies for Respiratory Pathologies

  2022cites this paper
• MS-based targeted profiling of oxylipins in COVID-19: A new insight into inflammation regulation

  2022cites this paper
• Lipoxins reduce obesity-induced adipose tissue inflammation in 3D-cultured human adipocytes and explant cultures

  2022cites this paper
• Novel aerosol treatment of airway hyper-reactivity and inflammation in a murine model of asthma with a soluble epoxide hydrolase inhibitor

  2022influential citation
• Leukotriene B4 limits the effectiveness of fish oil in an animal model of asthma

  2021cites this paper
• “Cell Membrane Theory of Senescence” and the Role of Bioactive Lipids in Aging, and Aging Associated Diseases and Their Therapeutic Implications

  2021cites this paper
• The oxylipin profile is associated with development of type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY)

  2021cites this paper
• Targeting Airway Smooth Muscle Hypertrophy in Asthma: An Approach Whose Time Has Come

  2021cites this paper
• Bioactive lipid-based therapeutic approach to COVID-19 and other similar infections

  2021cites this paper
• Functional significance of 8-isoprostanes in sinonasal disease and asthma.

  2021cites this paper
• Lipid-Derived Mediators are Pivotal to Leukocyte and Lung Cell Responses in Sepsis and ARDS

  2021cites this paper
• Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID‐19

  2021cites this paper
• Proresolving lipid mediators and liver disease.

  2021cites this paper
• Plasma oxylipin levels may predict Covid-19 patient outcomes. An observational and retrospective study.

  2021cites this paper
• Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development

  2021cites this paper
• Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis.

  2021cites this paper
• [Extracellular molecules controlling the contraction of airway smooth muscle and their potential contribution to bronchial hyperresponsiveness].

  2020cites this paper
• Cytochrome P450-Epoxygenated Fatty Acids Inhibit Müller Glial In�ammation

  2020cites this paper
• Cytochrome P450-epoxygenated fatty acids inhibit Müller glial inflammation

  2020cites this paper
• Eicosanoids

  2020cites this paper
• Carcinogenesis: Failure of resolution of inflammation?

  2020cites this paper
• Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression

  2020cites this paper
• Portable exhaled breath condensate metabolomics for daily monitoring of adolescent asthma

  2020cites this paper
• Role of epoxyeicosatrienoic acids in the lung.

  2020cites this paper
• ZDHXB-101 (3′,5-Diallyl-2, 4′-dihydroxy-[1,1′-biphen-yl]-3,5′-dicarbaldehyde) protects against airway remodeling and hyperresponsiveness via inhibiting both the activation of the mitogen-activated protein kinase and the signal transducer and activator of transcription-3 signaling pathways

  2020cites this paper
• Biosynthetic metabolomes of cysteinyl‐containing immunoresolvents

  2019cites this paper
• Inhibition of soluble epoxide hydrolase attenuates airway remodeling in a chronic asthma model.

  2019cites this paper
• Omega-3 and Omega-6 Intake Modifies Asthma Severity and Response to Indoor Air Pollution in Children.

  2019cites this paper
• Quenching the fires: Pro‐resolving mediators, air pollution, and smoking

  2019cites this paper
• Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders

  2019cites this paper
• Mechanisms for Non-eosinophilic Asthma

  2018cites this paper
• A composite of exhaled LTB4, LXA4, FeNO, and FEV1 as an “asthma classification ratio” characterizes childhood asthma

  2018cites this paper
• Amendment history : Corrigendum ( March 2018 ) ALX receptor ligands define a biochemical endotype for severe asthma

  2018cites this paper
• Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases.

  2018cites this paper
• Prominent release of lipoxygenase generated mediators in a murine house dust mite-induced asthma model.

  2018cites this paper
• Towards targeting resolution pathways of airway inflammation in asthma

  2018cites this paper
• Early Intravascular Events Are Associated with Development of Acute Respiratory Distress Syndrome. A Substudy of the LIPS‐A Clinical Trial

  2018cites this paper
• Fatty acid chemical mediator provides insights into the pathology and treatment of Parkinson’s disease

  2018cites this paper
• Chapter 7 Platelets , Inflammation and Respiratory Disease

  2018cites this paper
• Soluble epoxide hydrolase derived lipid mediators are elevated in bronchoalveolar lavage fluid from patients with sarcoidosis: a cross-sectional study

  2018cites this paper
• Biomarkers in asthma: state of the art

  2018cites this paper
• Plasma lipoxin A4 levels in childhood chronic spontaneous urticaria.

  2018cites this paper
• Eosinophilic and Noneosinophilic Asthma

  2018cites this paper
• Macrophage dysfunction in the pathogenesis and treatment of asthma

  2017cites this paper
• Bronchoprotective mechanisms for specialized pro-resolving mediators in the resolution of lung inflammation.

  2017cites this paper
• Role of lipid mediators in the regulation of oxidative stress and inflammatory responses in dairy cattle.

  2017cites this paper
• Therapeutic potential of omega‐3 fatty acid‐derived epoxyeicosanoids in cardiovascular and inflammatory diseases

  2017cites this paper
• Pro-Resolving Effects of Resolvin D2 in LTD4 and TNF-α Pre-Treated Human Bronchi

  2016cites this paper
• Blood biomarker panels of the late phase asthmatic response

  2016cites this paper
• Could relative abundance of airway lipoxins be the clue to restore corticosteroid sensitivity in severe asthma?

  2016cites this paper
• Severe Asthma: Have We Made Progress?

  2016cites this paper
• Rôle physiologique des époxy- et des polyhydroxy-éicosanoïdes dans les voies aériennes : résolution de l’inflammation et diminution de l’hyperréactivité bronchique.

  2016cites this paper
• Pseudomonas aeruginosa sabotages the generation of host proresolving lipid mediators

  2016cites this paper
• Future treatment for asthma

  2016cites this paper
• Novel n-3 PUFA monoacylglycerides of pharmacological and medicinal interest: Anti-inflammatory and anti-proliferative effects.

  2016cites this paper
• Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor.

  2016cites this paper
• Combinations of distinct long-chain polyunsaturated fatty acid species for improved dietary treatment against allergic bronchial asthma.

  2016cites this paper
• Biomarkers of asthma and allergic airway diseases.

  2015cites this paper
• Update in Asthma 2014.

  2015cites this paper
• Platelets, Inflammation and Respiratory Disease

  2015cites this paper
• In Vitro and in Vivo Anti-Inflammatory Effect of a Biotechnologically Modified Borage Seed Extract: Evidence for Lipid Pro-Resolving Mediators’ Implication in the Enhancement of Psoriatic and Atopic Dermatitis Lesions

  2015cites this paper
• Reversal of IL-13-induced inflammation and Ca(2+) sensitivity by resolvin and MAG-DHA in association with ASA in human bronchi.

  2015cites this paper
• Lipoxins and aspirin-triggered lipoxins in resolution of inflammation.

  2015cites this paper
• Specialized pro-resolving mediators: endogenous regulators of infection and inflammation

  2015cites this paper
• Lipoxins: nature’s way to resolve inflammation

  2015cites this paper
• Lipoxins and epoxyeicosatrienoic acids. Potential for inhibitors of soluble epoxide hydrolase in severe asthma?

  2014cites this paper
• The Overlooked Storm in Coronavirus Disease 2019 (COVID-19)?

  year unknowncites this paper